Letter by Ye et al Regarding Article, “Early Use of
N
-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [
N
-Acetylcysteine in Acute Myocardial Infarction])”